TG Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results
NEW YORK, Aug. 02, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the second quarter ending June 30, 2021 and recent company developments, along with a business outlook for the remainder 2021.
- NEW YORK, Aug. 02, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the second quarter ending June 30, 2021 and recent company developments, along with a business outlook for the remainder 2021.
- Generated $2.3M in total net UKONIQ revenue from launch through the end of Q2 2021, approximately 4 months.
- The Company will host a conference call today, August 2, 2021, at 8:30 AM ET, to discuss the Companys second quarter ended June 30, 2021 financial results and provide a business outlook for the remainder of 2021.
- To participate in the conference call, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), Conference Title: TG Therapeutics.